LAVA Therapeutics NV (LVTX) — Cash Flow Quality Index
Latest as of September 2022:
-14.59x
LAVA Therapeutics NV (LVTX) has a Cash Flow Quality Index of -14.59x as of September 2022. Operating cash flow of $-14.34 Million is below net income of $983.00K, suggesting accrual-heavy earnings not yet converted to cash. Also explore LVTX total assets for the complete picture of this company's asset base.
Cash Flow Quality Index
-14.59x
Operating CF / Net Income
Operating Cash Flow
$-14.34 Million
USD
Net Income
$983.00K
USD
Data as of
Sep 2022
Most recent filing
Annual Cash Flow Quality Index for LAVA Therapeutics NV (None–None)
Year-by-year earnings quality comparison for LAVA Therapeutics NV. For live market cap and the full company financial profile, see how much is LAVA Therapeutics NV worth.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.